Cargando…
Optimizing the Use of iPSC-CMs for Cardiac Regeneration in Animal Models
SIMPLE SUMMARY: In 2006, the first induced pluripotent stem cells were generated by reprogramming skin cells. Induced pluripotent stem cells undergo fast cell division, can differentiate into many different cell types, can be patient-specific, and do not raise ethical issues. Thus, they offer great...
Autores principales: | Bizy, Alexandra, Klos, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552322/ https://www.ncbi.nlm.nih.gov/pubmed/32887495 http://dx.doi.org/10.3390/ani10091561 |
Ejemplares similares
-
iPSC for modeling neurodegenerative disorders
por: Valadez-Barba, Valeria, et al.
Publicado: (2020) -
Recent progress of iPSC technology in cardiac diseases
por: Funakoshi, Shunsuke, et al.
Publicado: (2021) -
iPSC Therapy for Myocardial Infarction in Large Animal Models: Land of Hope and Dreams
por: Martínez-Falguera, Daina, et al.
Publicado: (2021) -
iPSC-based approach for human hair follicle regeneration
por: Vatanashevanopakorn, Chinnavuth, et al.
Publicado: (2023) -
iPSC Bioprinting: Where are We at?
por: Romanazzo, Sara, et al.
Publicado: (2019)